A comprehensive study of immunology repertoires in both preoperative stage and postoperative stage in patients with colorectal cancer

Abstract

In conclusion, CRC patients were presented with different immune repertoire in comparison with healthy controls. In this study, significant difference in TRBV and TRBJ gene usage in between case and control group could provide some potential biomarker for the diagnosis and the treatment of the patients with CRC.